Skip to main content

Childhood Hodgkin Lymphoma

Because of new and better therapies, cancer survival rates for children have improved dramatically during the last several decades. Scientists continue to search for the causes of childhood lymphoma so they can develop better treatments with less toxic side effects.

  • To access information about coping with childhood cancer, click here.
  • Click here for childhood Hodgkin lymphoma statistics.

Click on the links below for more information about childhood Hodgkin lymphoma

Caring for Kids and Adolescents with Blood Cancer: A Workbook for Families

Download or order a copy of the workbook which provides information, resources and worksheets to use throughout your child's cancer journey. Call an Information Specialist at 800.955.4572 to order a copy. 


A child's cancer diagnosis can bring with it feelings of uncertainty for parents and other family members. Suddenly, you're thrust into a fast-paced world of change, worry, fear and concern. You'll need to make treatment decisions while taking the time to comfort your child - and at the same time trying to cope with your own emotions.

Your child's treatment depends on certain factors:

  • The stage of the disease
  • The subtype of the disease
  • Fertility concerns
  • Other potential risk factors 

Your child's hematologist-oncologist (cancer specialist) should develop a treatment plan that limits the amount of therapy needed to bring about a remission. Be sure to ask the hematologist-oncologist about potential side effects and long-term effects when considering treatment options.

Children and young adults with HL are usually treated with one or more of the following approaches:

  • Chemotherapy
  • Image-guided radiation therapy (IGRT)
  • Targeted therapy
  • Immunotherapy (monoclonal antibodies and checkpoint inhibitors) 
  • Surgery (if a mass can be completely removed)
  • High-dose chemotherapy with stem cell transplantation

Drug Combinations

Children are treated with response-based, dose-dense regimens. Common drug combinations used to treat children and young adults include:

  • ABVE : Doxorubicin (Adriamycin®), bleomycin (Blenoxane®), vincristine, etoposide (Etopophos®) 
  • ABVE-PC: Doxorubicin, bleomycin, vincristine, etoposide, prednisone, cyclophosphamide 
  • ABVD: Doxorubicin, bleomycin, vincristine, etoposide, prednisone, cyclophosphamide  
  • Escalated BEACOPP: bleomycin, etoposide,  doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone 
  • Bv-AVE-PC: Brentuximab vedotin, doxorubicin, vincristine, etoposide, prednisone, cyclophosphamide  
  • COPP/ABV : cyclophosphamide, vincristine, procarbazine, prednisone,  doxorubicin, bleomycin, vinblastine 
  • Escalated BEACOPP: Bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone 
  • VAMP/COP: vincristine,  doxorubicin, methotrexate and prednisone alternating with cyclophosphamide, vincristine, and prednisone 
  • Stanford V:  Doxorubicin, vinblastine, mechlorethamine (Mustargen®), vincristine, bleomycin, etoposide, prednisone 
  • OEPA/COPDAC (for males): Vincristine, etoposide, prednisone, doxorubicin followed by cyclophosphamide, vincristine, prednisone, dacarbazine  
  • OPPA/COP (for females): Vincristine, procarbazine, prednisone, doxorubicin followed by cyclophosphamide, vincristine, procarbazine, prednisone  

For information about the drugs listed on this page, visit Drug Listings.

Clinical Trials

clinical trial may be an option when it comes to finding the right treatment for your child's cancer. Your child may have access to new or improved therapies under study and not yet on the market. Discuss with your child's doctor the possibility of taking part in a clinical trial, where treatment is administered in a safe, closely monitored environment.

Advances in treating childhood Hodgkin lymphoma, which have improved the cure rate and quality of life for survivors, are due, in large part, to the research of pediatric cooperative groups. The focus of ongoing research and clinical trials is to

  • Further improve the cure rate, especially for children with advanced HL
  • Improve quality of life
  • Minimize the risk of long-term and late effects associated with treatment (for example, infertility, impaired cardiac function and secondary cancers)
  • Improve the overall survival rate

Receive one-on-one navigation from an LLS Clinical Trial Specialist who will personally assist you throughout the entire clinical-trial process: Click Here

Survivorship and Special Healthcare Needs

After treatment, most children can expect to have full and productive lives. Many survivors return to school, attend college, enter the workforce, marry and become parents.

You may want to consider a survivorship program for your child that focuses on life after cancer. Many comprehensive cancer centers around the country offer these programs.

Our Survivorship Workbook allows you to collect all the important information you and your child needs throughout diagnosis, treatment, follow-up care, and long-term management of a blood cancer. 

Follow-Up Care

Your child should visit his or her pediatrician or doctor at least once a year for a complete physical exam and any additional needed tests. Your child's oncologist should also regularly examine your child.

Regular doctor visits are encouraged to

  • Enable doctors to assess the full effect of therapy
  • Detect and treat disease recurrence
  • Identify and manage long-term and late effects of treatment

Your pediatrician should recommend a schedule for having your child's learning skills assessed. If your child appears to be experiencing learning disabilities, special education methods can help.

Long-Term and Late Effects of Treatment

Some side effects of cancer treatment, such as fatigue, can linger for months or years after therapy. Some medical conditions like heart disease and other cancers may not appear until years after treatment ends. Long-term and late effects can affect your child's physical, mental and cognitive (brain function) health.

Most childhood survivors of lymphoma don't develop significant long-term or late effects of treatment. However, for some patients the effects can be severe.

Long-Term and Late Effects of Chemotherapy

Children treated for lymphoma may be at increased risk for

  • Fatigue 
  • Cardiovascular (heart) disease 
  • Hypothyroidism
  • Fertility issues 

Some long-term and late effects become evident with maturation (puberty), growth and the normal aging process. Early intervention and healthy lifestyle practices (not smoking, good nutrition, exercise, regular screenings and follow-up) may have a positive effect on the occurrence and/or severity of long-term and late effects.

Long-Term and Late Effects of Radiation Therapy

Children who receive radiation therapy to the chest are at an increased risk of breast cancer later in life. Patients who received radiation therapy to the chest (mediastinal) area should:

  • Perform monthly self-breast exams
  • Have an annual clinical breast exam performed by a healthcare provider at least once a year until age 25 and then every 6 months after
  • Have a yearly mammogram starting at age 25 or 8 years after treatment (whichever comes last)

Children who've undergone chest radiation therapy should have baseline testing for heart function. This should be followed by testing every three to five years after treatment or more regularly if any abnormalities are found.

Returning to School

Learning disabilities can begin during treatment or appear months or years after treatment. Educate family members, friends, school personnel and healthcare providers about your child's possible long-term and late effects of treatment. Talk with teachers about your child's needs before he or she returns to school. Work with your child's teachers and medical providers to develop a program tailored to his or her needs that features baseline testing, special accommodations and long-term planning.

Click here to read about children with cancer returning to school.

Related Links